Candel Therapeutics, Inc. (CADL)’s CAN-2409 Advances with FDA RMAT Status for Localized Prostate Cancer
Candel Therapeutics, Inc.
Candel Therapeutics Inc. (CADL)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Portolan Capital Management George Mccabe | 1,384,142 | $7,059,124 | -15% | 0.38% |
| 2. | Citadel Investment Group Ken Griffin | 252,291 | $1,286,684 | 0% | |
| 3. | Millennium Management Israel Englander | 136,670 | $697,017 | 0% | |
| 4. | 123,900 | $631,890 | -60% | 0% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 103,847 | $529,621 | -36% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.00 | 750,000 | $4,500,000.00 | 1,303,752 | 2024-12-16 | Filing | |
| $6.00 | 500,000 | $3,000,000.00 | 1,142,406 | 2024-12-16 | Filing | |
| $1.92 | 23,950 | $45,984.00 | 152,000 | 2022-12-09 | Filing | |
| $1.68 | 3,050 | $5,124.00 | 128,050 | 2022-12-08 | Filing | |
| $1.61 | 1,238 | $1,993.18 | 2,738 | 2022-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.98 | 937 | $6,540.26 | 52,493 | 2025-07-28 | Filing | |
| $5.04 | 781 | $3,936.24 | 52,493 | 2025-06-30 | Filing | |
| $8.76 | 45,316 | $396,995.35 | 52,493 | 2025-03-18 | Filing | |
| $8.76 | 32,146 | $281,672.90 | 96,527 | 2025-03-18 | Filing | |
| $9.00 | 400 | $3,601.00 | 225,740 | 2025-03-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,233,385 | $41,990,263 | 0% | |
| 2. | 2,580,517 | $13,160,637 | 6.68% | |
| 3. | 2,379,330 | $12,134,582 | 0% | |
| 4. | 2,007,112 | $10,236,272 | 0% | |
| 5. | 928,197 | $4,734,652 | 0% |
News See All
Candel Therapeutics, Inc. (CADL) to Present Positive Phase 3 Prostate Cancer Data at ASCO 2025
Candel Therapeutics, Inc.
Hedge Fund and Insider Trading News: Ray Dalio, Michael Novogratz, Bitwise Asset Management, Goldman Sachs Group Inc. (GS), Candel Therapeutics Inc (CADL), Cintas Corporation (CTAS), and More
The asset-management arm of Michael Novogratz’s Galaxy Digital is aiming to hire its first chief operating officer as the division scales and increasingly moves into running actively managed crypto ...
Hedge Fund Resource Center Billionaire Hedge Funds
